Ramesh Kumar

Direttore/Membro del Consiglio presso OCUGEN, INC.

Patrimonio netto: - $ in data 31/05/2024

68 anni

Health Technology

Consumer Services

Commercial Services

Posizioni attive di Ramesh Kumar

Società	Posizione	Inizio	Fine
OCUGEN, INC.	Independent Dir/Board Member	27/09/2019	-
	Direttore/Membro del Consiglio	27/09/2019	-
	Comptroller/Controller/Auditor	-	15/09/2023
Ocugen OpCo, Inc.	Direttore/Membro del Consiglio	01/06/2019	-

Società	Posizione	Inizio	Fine
TRAWS PHARMA, INC.	Direttore/Membro del Consiglio	29/04/2011	15/01/2019
	Amministratore Delegato	22/12/1998	15/01/2019
	Fondatore	22/12/1998	15/01/2019
	Presidente	22/12/1998	21/06/2018
BRISTOL-MYERS SQUIBB COMPANY	Direttore Tecnico/Scientifico/R&S	-	-
Nextran Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million.	Direttore/Membro del Consiglio	-	-
Kimeragen, Inc.	Corporate Officer/Principal	-	-
Princeton University	Corporate Officer/Principal	-	-
National Cancer Institute National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD.	Corporate Officer/Principal	-	-

University of Illinois	Doctorate Degree
Panjab University Chandigarh	Graduate Degree

Distribuzione geografica

Posizioni

Director/Board Member	4
Corporate Officer/Principal	3
Chief Executive Officer	1

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
BRISTOL-MYERS SQUIBB COMPANY	Health Technology
TRAWS PHARMA, INC.	Health Technology

Aziende private	5
Kimeragen, Inc.	Commercial Services
Nextran Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million.	Health Technology
National Cancer Institute National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD.	Miscellaneous
Ocugen, Inc.
Ocugen OpCo, Inc.